19 research outputs found

    In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

    Get PDF
    CXCR4 is a G-protein-coupled receptor that mediates recruitment of blood cells toward its ligand SDF-1. In cancer, high CXCR4 expression is frequently associated with tumor dissemination and poor prognosis. We evaluated the novel CXCR4 probe [(68)Ga]Pentixafor for in vivo mapping of CXCR4 expression density in mice xenografted with human CXCR4-positive MM cell lines and patients with advanced MM by means of positron emission tomography (PET). [(68)Ga]Pentixafor PET provided images with excellent specificity and contrast. In 10 of 14 patients with advanced MM [(68)Ga]Pentixafor PET/CT scans revealed MM manifestations, whereas only nine of 14 standard [(18)F]fluorodeoxyglucose PET/CT scans were rated visually positive. Assessment of blood counts and standard CD34(+) flow cytometry did not reveal significant blood count changes associated with tracer application. Based on these highly encouraging data on clinical PET imaging of CXCR4 expression in a cohort of MM patients, we conclude that [(68)Ga]Pentixafor PET opens a broad field for clinical investigations on CXCR4 expression and for CXCR4-directed therapeutic approaches in MM and other diseases

    Multitechnique Characterization of a Polyaniline Iron Carbon Oxygen Reduction Catalyst

    No full text
    This paper summarizes a XANES, XPS, XRD, and Mo amp; 776;ssbauer study of an oxygen reduction reaction ORR catalyst obtained via a heat treatment of polyaniline, iron, and carbon black. The catalyst was characterized at several critical synthesis stages and following heat treatment at various temperatures. The effect of sulfur during the synthesis was also investigated. XANES linear combination fitting XANES LCF was used to determine the speciation of iron using 16 iron standards. The highest ORR activity was measured with a catalyst heat treated at 900 C, with the largest Fe amp; 8722;Nx content, as determined by the XANES LCF, also characterized by the highest microporosity. An absence or a reduction in the amount of a sulfur based oxidant in the aniline polymerization was found to lead to an increase in the amount of iron carbide formed during the heat treatment and a decrease in the number of Fe amp; 8722;N4 centers, thus attesting to an indirect beneficial role of sulfur in the catalyst synthesis. Using principal component analysis PCA , a good correlation was found between the ORR activity and the presence of Fe amp; 8722;Nx structure

    The effects of porcine somatotropin (pST) and dietary lysine level on growth performance and carcass characteristics of finishing swine

    Get PDF
    Seventy-two finishing pigs averaging 130 lb were utilized to determine the effects of PST and dietary lysine on growth performance and carcass characteristics. Pigs were injected daily with 4 mg PST in the extensor muscle of the neck and fed either a pelleted corn-sesame meal diet (.6% lysine, 17.7% crude protein) or diets containing .8, 1.0, 1.2, or 1.4% lysine provided by L-lysine HCl. All diets were formulated to contain at least 200% of NRC (1979) recommendations for other amino acids. Control pigs received a placebo injection and the .6% lysine diet. Increasing levels of dietary lysine resulted in increased average daily gain (ADG) and improved feed conversion (F/G; linear and quadratic, P<.01) for PST-treated pigs. Adjusted backfat thickness (ABF) was not affected by dietary lysine; however, PST-treated pigs had less backfat (P<.05) than control pigs. Longissimus muscle area (LMA), trimmed ham, and loin weights increased as dietary lysine was increased among PST-treated pigs (linear and quadratic, P<.01). Percentage of moisture and crude protein of the longissimus muscle increased, (linear P<.05, linear and quadratic P<.05, respectively), whereas dry matter and fat content decreased (linear P<.05). Similar trends in composition were observed for other ham muscles (semimembranous, semitendinosus, and biceps femoris). Heart, liver, kidney, spleen, and lung weights were not affected by PST or lysine treatment. Urea concentrations in plasma on day 28 decreased linearly (P<.O I) as lysine level increased, whereas plasma lysine and insulin increased (linear and quadratic, P<.OI). Plasma glucose and free fatty acid concentrations on day 28 tended to increase (quadratic P<. I0) with increasing dietary lysine level. Plasma somatotropin level was elevated 2 to 3 times in PST-treated pigs compared to control pigs, but was not affected by dietary lysine level. Our results indicate a relatively high requirement for lysine in PST-treated pigs. Growth performance and carcass traits were optimized at dietary lysine levels of 1.2 to 1.4%, which corresponds to lysine intakes of 30 to 36 g/day. These results demonstrate that PST-administration nearly doubles the lysine requirement of finishing swine
    corecore